Chemoinformaics analysis of NORTRICYCLOEKASANTALIC-ACID
Molecular Weight | 395.503 | nRot | 7 |
Heavy Atom Molecular Weight | 366.271 | nRig | 24 |
Exact Molecular Weight | 395.221 | nRing | 6 |
Solubility: LogS | -4.639 | nHRing | 1 |
Solubility: LogP | 4.112 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 3 | No. of Arom Atom | 9 |
No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
nHA | 4 | APOL | 63.453 |
nHD | 2 | BPOL | 33.109 |
QED | 0.694 |
Synth | 3.619 |
Natural Product Likeliness | -1.003 |
NR-PPAR-gamma | 0.864 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.015 |
Pgp-sub | 0.014 |
HIA | 0.004 |
CACO-2 | -4.929 |
MDCK | 0.000027 |
BBB | 0.053 |
PPB | 0.924548 |
VDSS | 0.326 |
FU | 0.0273984 |
CYP1A2-inh | 0.119 |
CYP1A2-sub | 0.078 |
CYP2c19-inh | 0.495 |
CYP2c19-sub | 0.066 |
CYP2c9-inh | 0.697 |
CYP2c9-sub | 0.971 |
CYP2d6-inh | 0.271 |
CYP2d6-sub | 0.114 |
CYP3a4-inh | 0.162 |
CYP3a4-sub | 0.029 |
CL | 2.941 |
T12 | 0.072 |
hERG | 0.025 |
Ames | 0.013 |
ROA | 0.133 |
SkinSen | 0.041 |
Carcinogencity | 0.395 |
EI | 0.015 |
Respiratory | 0.607 |
NR-Aromatase | 0.013 |
Antiviral | Yes |
Prediction | 0.634596 |